FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386029042> ?p ?o ?g. }

• W4386029042 endingPage "6142" @default.
• W4386029042 startingPage "6142" @default.
• W4386029042 abstract "In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity of drugs that were available in Kazakhstan during the acute phase of the epidemic against SARS-CoV-2. Antiviral activity is reported for Favipiravir, Tilorone, and Cridanimod, which are registered drugs used for the treatment of respiratory viral infections in Kazakhstan. A licorice (Glycyrrhiza glabra) extract was also incorporated into this study because it offered an opportunity to develop plant-derived antivirals. The Favipiravir drug, which had been advertised in local markets as an anti-COVID cure, showed no activity against SARS-CoV-2 in cell cultures. On the contrary, Cridanimod showed impressive high activity (median inhibitory concentration 66 μg/mL) against SARS-CoV-2, justifying further studies of Cridanimod in clinical trials. Tilorone, despite being in the same pharmacological group as Cridanimod, stimulated SARS-CoV-2 replication in cultures. The licorice extract inhibited SARS-CoV-2 replication in cultures, with a high median effective concentration of 16.86 mg/mL. Conclusions: The synthetic, low-molecular-weight compound Cridanimod suppresses SARS-CoV-2 replication at notably low concentrations, and this drug is not toxic to cells at therapeutic concentrations. In contrast to its role as an inducer of interferons, Cridanimod is active in cells that have a genetic defect in interferon production, suggesting a different mechanism of action. Cridanimod is an attractive drug for inclusion in clinical trials against SARS-CoV-2 and, presumably, other coronaviruses. The extract from licorice shows low activity against SARS-CoV-2. At the same time, high doses of 2 g/kg of this plant extract show little or no acute toxicity in animal studies; for this reason, licorice products can still be considered for further development as a safe, orally administered adjunctive therapy." @default.
• W4386029042 created "2023-08-22" @default.
• W4386029042 creator A5004159291 @default.
• W4386029042 creator A5004392079 @default.
• W4386029042 creator A5007900081 @default.
• W4386029042 creator A5018971334 @default.
• W4386029042 creator A5025549501 @default.
• W4386029042 creator A5038664420 @default.
• W4386029042 creator A5047510278 @default.
• W4386029042 creator A5063665259 @default.
• W4386029042 creator A5063960994 @default.
• W4386029042 creator A5071640397 @default.
• W4386029042 date "2023-08-19" @default.
• W4386029042 modified "2023-09-27" @default.
• W4386029042 title "Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked" @default.
• W4386029042 cites W2035256325 @default.
• W4386029042 cites W2057326152 @default.
• W4386029042 cites W2105729094 @default.
• W4386029042 cites W2221603109 @default.
• W4386029042 cites W2474853321 @default.
• W4386029042 cites W2739679816 @default.
• W4386029042 cites W2768755579 @default.
• W4386029042 cites W2793533360 @default.
• W4386029042 cites W2991922584 @default.
• W4386029042 cites W3005212621 @default.
• W4386029042 cites W3013179208 @default.
• W4386029042 cites W3023724901 @default.
• W4386029042 cites W3035628751 @default.
• W4386029042 cites W3036617393 @default.
• W4386029042 cites W3048671222 @default.
• W4386029042 cites W3087747244 @default.
• W4386029042 cites W3089277225 @default.
• W4386029042 cites W3093194765 @default.
• W4386029042 cites W3107514306 @default.
• W4386029042 cites W3134425030 @default.
• W4386029042 cites W3158369907 @default.
• W4386029042 cites W3165455238 @default.
• W4386029042 cites W3167245970 @default.
• W4386029042 cites W3168461337 @default.
• W4386029042 cites W3196131249 @default.
• W4386029042 cites W3215681136 @default.
• W4386029042 cites W4200051875 @default.
• W4386029042 cites W4200277291 @default.
• W4386029042 cites W4200369357 @default.
• W4386029042 cites W4200500215 @default.
• W4386029042 cites W4210759317 @default.
• W4386029042 cites W4220961873 @default.
• W4386029042 cites W4280507440 @default.
• W4386029042 cites W4309343993 @default.
• W4386029042 cites W4384698745 @default.
• W4386029042 cites W655885092 @default.
• W4386029042 doi "https://doi.org/10.3390/molecules28166142" @default.
• W4386029042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37630394" @default.
• W4386029042 hasPublicationYear "2023" @default.
• W4386029042 type Work @default.
• W4386029042 citedByCount "0" @default.
• W4386029042 crossrefType "journal-article" @default.
• W4386029042 hasAuthorship W4386029042A5004159291 @default.
• W4386029042 hasAuthorship W4386029042A5004392079 @default.
• W4386029042 hasAuthorship W4386029042A5007900081 @default.
• W4386029042 hasAuthorship W4386029042A5018971334 @default.
• W4386029042 hasAuthorship W4386029042A5025549501 @default.
• W4386029042 hasAuthorship W4386029042A5038664420 @default.
• W4386029042 hasAuthorship W4386029042A5047510278 @default.
• W4386029042 hasAuthorship W4386029042A5063665259 @default.
• W4386029042 hasAuthorship W4386029042A5063960994 @default.
• W4386029042 hasAuthorship W4386029042A5071640397 @default.
• W4386029042 hasBestOaLocation W43860290421 @default.
• W4386029042 hasConcept C126322002 @default.
• W4386029042 hasConcept C140704245 @default.
• W4386029042 hasConcept C142724271 @default.
• W4386029042 hasConcept C159047783 @default.
• W4386029042 hasConcept C204787440 @default.
• W4386029042 hasConcept C2522874641 @default.
• W4386029042 hasConcept C2778993495 @default.
• W4386029042 hasConcept C2779134260 @default.
• W4386029042 hasConcept C2779756493 @default.
• W4386029042 hasConcept C2779772310 @default.
• W4386029042 hasConcept C2780035454 @default.
• W4386029042 hasConcept C3008058167 @default.
• W4386029042 hasConcept C524204448 @default.
• W4386029042 hasConcept C556039675 @default.
• W4386029042 hasConcept C71924100 @default.
• W4386029042 hasConcept C86803240 @default.
• W4386029042 hasConcept C98274493 @default.
• W4386029042 hasConceptScore W4386029042C126322002 @default.
• W4386029042 hasConceptScore W4386029042C140704245 @default.
• W4386029042 hasConceptScore W4386029042C142724271 @default.
• W4386029042 hasConceptScore W4386029042C159047783 @default.
• W4386029042 hasConceptScore W4386029042C204787440 @default.
• W4386029042 hasConceptScore W4386029042C2522874641 @default.
• W4386029042 hasConceptScore W4386029042C2778993495 @default.
• W4386029042 hasConceptScore W4386029042C2779134260 @default.
• W4386029042 hasConceptScore W4386029042C2779756493 @default.
• W4386029042 hasConceptScore W4386029042C2779772310 @default.
• W4386029042 hasConceptScore W4386029042C2780035454 @default.
• W4386029042 hasConceptScore W4386029042C3008058167 @default.
• W4386029042 hasConceptScore W4386029042C524204448 @default.

• next